Rafferty Asset Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Sell |
75,235
-37,347
| -33% | -$419K | ﹤0.01% | 792 |
|
|
2025
Q1 | $515K | Sell |
112,582
-23,835
| -17% | -$109K | ﹤0.01% | 857 |
|
|
2024
Q4 | $769K | Sell |
136,417
-74,539
| -35% | -$420K | ﹤0.01% | 834 |
|
|
2024
Q3 | $1.02M | Sell |
210,956
-15,392
| -7% | -$74.5K | ﹤0.01% | 794 |
|
|
2024
Q2 | $1.1M | Sell |
226,348
-247,235
| -52% | -$1.21M | ﹤0.01% | 793 |
|
|
2024
Q1 | $6.29M | Buy |
473,583
+121,679
| +35% | +$1.62M | 0.02% | 418 |
|
|
2023
Q4 | $4.91M | Buy |
351,904
+32,104
| +10% | +$448K | 0.02% | 449 |
|
|
2023
Q3 | $4.24M | Buy |
319,800
+39,882
| +14% | +$529K | 0.02% | 427 |
|
|
2023
Q2 | $5.25M | Buy |
279,918
+16,880
| +6% | +$317K | 0.03% | 402 |
|
|
2023
Q1 | $3.79M | Sell |
263,038
-109,643
| -29% | -$1.58M | 0.03% | 451 |
|
|
2022
Q4 | $7.21M | Buy |
372,681
+193,914
| +108% | +$3.75M | 0.06% | 293 |
|
|
2022
Q3 | $6.14M | Buy |
+178,767
| New | +$6.14M | 0.07% | 281 |
|
|
2022
Q2 | – | Sell |
-185,009
| Closed | -$4.22M | – | 1232 |
|
|
2022
Q1 | $4.22M | Buy |
185,009
+41,635
| +29% | +$950K | 0.03% | 419 |
|
|
2021
Q4 | $5.29M | Buy |
+143,374
| New | +$5.29M | 0.03% | 373 |
|